UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent trends in preclinical drug-drug interaction studies of flavonoids - Review of case studies, issues and perspectives

Phytotherapy research, 2015-11, Vol.29 (11), p.1679-1691

Srinivas, Nuggehally R.

2015

Volltextzugriff (PDF)

Pronounced influence of presystemic metabolism on the metabolic disposition of imrecoxib in renally impaired patients

European journal of clinical pharmacology, 2020-03, Vol.76 (3), p.469-471

Srinivas, Nuggehally R.

2020

Volltextzugriff (PDF)

International Normalized Ratio–Dependent Clearance of Dexmedetomidine: Possible Clinical Implications

Anesthesia and analgesia, 2020-05, Vol.130 (5), p.e153-e153

Srinivas, Nuggehally R

2020

Volltextzugriff (PDF)

Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics

Clinical pharmacokinetics, 2018-11, Vol.57 (11), p.1385-1398

2018

Volltextzugriff (PDF)

Stereoselective Pharmacokinetic Disposition of Ketorolac Following Drug Administration to Periarticular Tissues in Patients

Anesthesia and analgesia, 2020-01, Vol.130 (1), p.e33-e34

Srinivas, Nuggehally R

2020

Volltextzugriff (PDF)

Reduced Ketobemidone Usage in Quadratus Lumborum Block Patients After Cesarean Delivery: Clinical Pharmacology Views

Anesthesia and analgesia, 2018-07, Vol.127 (1), p.311-311

Srinivas, Nuggehally R

2018

Volltextzugriff (PDF)

Clinical pharmacokinetics of panobinostat, a novel histone deacetylase (HDAC) inhibitor: review and perspectives

Xenobiotica, 2017-04, Vol.47 (4), p.354-368

Srinivas, Nuggehally R.

2017

Volltextzugriff (PDF)

Lack of Translatable Proinflammatory Cytokines in Cerebrospinal Fluid in Rats With Increased Hyperalgesia With or Without Fentanyl Treatment

Anesthesia and analgesia, 2018-06, Vol.126 (6), p.2150-2150

Srinivas, Nuggehally R

2018

Volltextzugriff (PDF)

Antiretroviral Therapy With Efavirenz in HIV‐Infected Pregnant Women: Understanding the Possible Mechanisms for Drug–Drug Interaction

Clinical pharmacology and therapeutics, 2018-04, Vol.103 (4), p.570-570

Srinivas, Nuggehally R.

2018

Volltextzugriff (PDF)

Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: What is missing?

Cancer chemotherapy and pharmacology, 2016-11, Vol.78 (5), p.1097-1098

Srinivas, Nuggehally R.

2016

Volltextzugriff (PDF)

Combination of flavonoids with azole drugs for fungal infections: key pharmacokinetic challenges

Future microbiology, 2019-06, Vol.14 (9), p.733-738

Srinivas, Nuggehally R

2019

Volltextzugriff (PDF)

Reappraisal and perspectives of clinical drug-drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus

Xenobiotica, 2018-01, Vol.48 (1), p.89-108

2018

Volltextzugriff (PDF)

Arenobufagin: A potential novel opportunity for prostate cancer treatment – Intriguing mechanistic data but some questions on in vivo translatability

Pharmacological research, 2018-02, Vol.128, p.400-401

Srinivas, Nuggehally R.

2018

Volltextzugriff (PDF)

Pharmacokinetic Interaction of Rifampicin with Oral Versus Intravenous Anticancer Drugs: Challenges, Dilemmas and Paradoxical Effects Due to Multiple Mechanisms

Drugs in R&D, 2016-06, Vol.16 (2), p.141-148

Srinivas, Nuggehally R.

2016

Volltextzugriff (PDF)

Review of Clinical Pharmacokinetics of Avibactam, A Newly Approved non-β lactam β-lactamase Inhibitor Drug, In Combination Use With Ceftazidime

Drug research (Stuttgart), 2019-05, Vol.69 (5), p.245-255

2019

Volltextzugriff (PDF)

Influence of Morbid Obesity on the Clinical Pharmacokinetics of Various Anti-Infective Drugs: Reappraisal Using Recent Case Studies—Issues, Dosing Implications, and Considerations

American journal of therapeutics, 2018-03, Vol.25 (2), p.e224-e246

Srinivas, Nuggehally R.

2018

Volltextzugriff (PDF)

Considerations and perspectives on the practice of incurred sample reanalysis assessment for chiral drugs

Biomedical chromatography, 2024-09, Vol.38 (9), p.e5954-n/a

2024

Volltextzugriff (PDF)

Clinical Pharmacology Considerations for Development of β Lactamase Inhibitor Combination with Antibiotics

Drug research (Stuttgart), 2018-09, Vol.68 (9), p.536-540

Srinivas, Nuggehally

2018

Volltextzugriff (PDF)

Improved oral bioavailability and brain accumulation of afatinib due to dual inhibition of the efflux mechanisms of BCRP and Pgp transporters —What next?

Pharmacological research, 2017-09, Vol.123, p.143-143

Srinivas, Nuggehally R.

2017

Volltextzugriff (PDF)

Comment on: “Modeling the Relationship between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer”

Clinical pharmacokinetics, 2017-02, Vol.56 (2), p.211-212

Srinivas, Nuggehally R.

2017

Volltextzugriff (PDF)

Comments on:“In vitro and in vivo pharmacokinetics and toxicity evaluation of curcumin incorporated titanium dioxide nanoparticles for biomedical applications”

Chemico-biological interactions, 2017-11, Vol.277, p.145-145

Srinivas, Nuggehally R.

2017

Volltextzugriff (PDF)

Incurred sample reanalysis (ISR) in clinical bioanalysis—Is it really a one‐size‐fits‐all solution?

Biomedical chromatography, 2024-03, Vol.38 (3), p.e5843-n/a

2024

Volltextzugriff (PDF)

The Interesting Case of Acyclovir Delivered Using Chitosan in Humans: Is it a Drug Issue or Formulation Issue?

Pharmaceutical research, 2016-03, Vol.33 (3), p.543-547

Srinivas, Nuggehally R.

2016

Volltextzugriff (PDF)

Cranberry juice ingestion and clinical drug-drug interaction potentials; review of case studies and perspectives

Journal of pharmacy & pharmaceutical sciences, 2013-01, Vol.16 (2), p.289

Srinivas, Nuggehally R

2013

Volltextzugriff (PDF)

Clinical drug-drug interactions of bosentan, a potent endothelial receptor antagonist, with various drugs: Physiological role of enzymes and transporters

General physiology and biophysics, 2016-07, Vol.35 (3), p.243-258

Srinivas, Nuggehally R

2016

Volltextzugriff (PDF)

1 – 25 von 360

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(331)
Mit Volltextzugriff
(260)

Publikationsform

Sprache

Englisch
(358)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(292)
Life Sciences & Biomedicine
(288)
Pharmacology & Pharmacy
(262)
Humans
(191)
Chemistry
(129)
Physical Sciences
(129)
Animals
(115)
Pharmacokinetics
(114)
Chemistry, Analytical
(110)
Biochemistry & Molecular Biology
(105)
Biochemical Research Methods
(103)
Male
(79)
Rats
(62)
Pharmacology/toxicology
(57)
Biological And Medical Sciences
(54)
Reproducibility Of Results
(54)
Medical Sciences
(53)
Pharmacology. Drug Treatments
(53)
Chromatography, High Pressure Liquid - Methods
(43)
Drug Interactions
(41)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recent trends in preclinical drug-drug interaction studies of flavonoids - Review of case studies, issues and perspectives

Pronounced influence of presystemic metabolism on the metabolic disposition of imrecoxib in renally impaired patients

International Normalized Ratio–Dependent Clearance of Dexmedetomidine: Possible Clinical Implications

Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics

Stereoselective Pharmacokinetic Disposition of Ketorolac Following Drug Administration to Periarticular Tissues in Patients

Reduced Ketobemidone Usage in Quadratus Lumborum Block Patients After Cesarean Delivery: Clinical Pharmacology Views

Clinical pharmacokinetics of panobinostat, a novel histone deacetylase (HDAC) inhibitor: review and perspectives

Lack of Translatable Proinflammatory Cytokines in Cerebrospinal Fluid in Rats With Increased Hyperalgesia With or Without Fentanyl Treatment

Antiretroviral Therapy With Efavirenz in HIV‐Infected Pregnant Women: Understanding the Possible Mechanisms for Drug–Drug Interaction

Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: What is missing?

Combination of flavonoids with azole drugs for fungal infections: key pharmacokinetic challenges

Reappraisal and perspectives of clinical drug-drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus

Arenobufagin: A potential novel opportunity for prostate cancer treatment – Intriguing mechanistic data but some questions on in vivo translatability

Pharmacokinetic Interaction of Rifampicin with Oral Versus Intravenous Anticancer Drugs: Challenges, Dilemmas and Paradoxical Effects Due to Multiple Mechanisms

Review of Clinical Pharmacokinetics of Avibactam, A Newly Approved non-β lactam β-lactamase Inhibitor Drug, In Combination Use With Ceftazidime

Influence of Morbid Obesity on the Clinical Pharmacokinetics of Various Anti-Infective Drugs: Reappraisal Using Recent Case Studies—Issues, Dosing Implications, and Considerations

Considerations and perspectives on the practice of incurred sample reanalysis assessment for chiral drugs

Clinical Pharmacology Considerations for Development of β Lactamase Inhibitor Combination with Antibiotics

Improved oral bioavailability and brain accumulation of afatinib due to dual inhibition of the efflux mechanisms of BCRP and Pgp transporters —What next?

Comment on: “Modeling the Relationship between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer”

Comments on:“In vitro and in vivo pharmacokinetics and toxicity evaluation of curcumin incorporated titanium dioxide nanoparticles for biomedical applications”

Incurred sample reanalysis (ISR) in clinical bioanalysis—Is it really a one‐size‐fits‐all solution?

The Interesting Case of Acyclovir Delivered Using Chitosan in Humans: Is it a Drug Issue or Formulation Issue?

Cranberry juice ingestion and clinical drug-drug interaction potentials; review of case studies and perspectives

Clinical drug-drug interactions of bosentan, a potent endothelial receptor antagonist, with various drugs: Physiological role of enzymes and transporters

Suchergebnisse filtern